Holen Sie sich die Stockscreener-App
9.05
1.74%
-0.16
Handel nachbörslich:
9.09
0.04
+0.44%
Schlusskurs vom Vortag:
$9.21
Offen:
$9.39
24-Stunden-Volumen:
4.36M
Relative Volume:
0.81
Marktkapitalisierung:
$1.58B
Einnahmen:
$2.61B
Nettoeinkommen (Verlust:
$-1.01B
KGV:
-0.367
EPS:
-24.66
Netto-Cashflow:
$195.87M
1W Leistung:
-7.75%
1M Leistung:
-8.03%
6M Leistung:
-28.91%
1J Leistung:
-47.29%
1-Tages-Spanne:
$8.95
$9.48
1-Wochen-Bereich:
$8.74
$10.12
52-Wochen-Spanne:
$6.76
$22.54
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| TDOC | 9.05 | 1.58B | 2.61B | -1.01B | 195.87M | -24.66 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today - AOL
Telemental Health Market: Growth, Opportunities, and Challenges - openPR
Brokers Offer Predictions for Teladoc Health FY2024 Earnings - MarketBeat
Where Will Teladoc Be in 5 Years? - Yahoo Finance
TDOC (Teladoc Health) Cash From Other Investing Activities : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Goldman Sachs Initiates Coverage of Teladoc Health (TDOC) with Buy Recommendation - MSN
Teladoc Health (NYSE:TDOC) Shares Gap UpWhat's Next? - MarketBeat
Teladoc started at buy at Goldman Sachs on membership, revenue growth - MSN
Teladoc Health (NYSE:TDOC) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Goldman Sachs sets Teladoc target at $14 with Buy rating - Investing.com
Teladoc's SWOT analysis: virtual care leader's stock faces growth hurdles - Investing.com
Is Teladoc Health Stock A Buy? - Barchart
Entropy Technologies LP Reduces Stock Position in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Is Teladoc Health Stock a Buy? - AOL
Virtual Care Market to Achieve a Superb CAGR from 2024 To 2031 - openPR
Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Future-Proofing Growth of Telemedicine Appointment Tools - openPR
Hims & Hers, Talkspace among Q3 winners in digital health - Modern Healthcare
Distance Health Technology Market: Future Scope, Growth - openPR
Telehealth Solutions Market Outlook: Competitor Insights - openPR
(TDOC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Robeco Institutional Asset Management B.V. Boosts Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Telehealth company Boulder Care raises profile with prominent executive hires - Fierce healthcare
Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 - StockTitan
Online Doctor Consultation Market to Grow by USD 38.87 Billion from 2024-2028, Driven by Rising Infectious Diseases and AI-Driven Market TransformationTechnavio - The Malaysian Reserve
ISRG: 3 Healthcare Stocks Innovating with AI - StockNews.com
Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit - MSN
Every Teladoc Investor Should Keep an Eye on This Number - Yahoo Finance
Teladoc Health (NYSE:TDOC) Trading Down 7.3%What's Next? - MarketBeat
Teladoc Health Q4 EPS Estimate Lowered by Leerink Partnrs - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Simply Wall St
Teladoc Health (NYSE:TDOC) Price Target Raised to $12.00 - MarketBeat
Leerink Partnrs Comments on Teladoc Health Q1 Earnings - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Q3 2024 Earnings Call Transcript - Insider Monkey
TDOC (Teladoc Health) Cash From Discontinued Investing Acti - GuruFocus.com
Earnings call: Teladoc Health reports mixed Q3 results, plans for 2025 By Investing.com - Investing.com South Africa
Earnings call: Teladoc Health reports mixed Q3 results, plans for 2025 - Investing.com Australia
'3Q print less bad than feared', Citi lifts Teladoc stock PT to $11 - Investing.com
Former Teladoc Executive and Healthcare Operations Veteran Jennifer Close Joins Curai Health as Chief Operating Officer - PR Newswire
Teladoc Health (NYSE:TDOC) Sees Unusually-High Trading Volume on Earnings Beat - MarketBeat
December 13th Options Now Available For Teladoc Health (TDOC) - Nasdaq
Teladoc stock rises 7% as Q3 earnings, forecast top Street estimates - MSN
Teladoc stock soars 11% after earnings beat By Investing.com - Investing.com South Africa
Teladoc (TDOC) PT Raised to $11 at Citi - StreetInsider.com
Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navi - GuruFocus.com
Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navigating Challenges and Strategic ... - Yahoo Finance
Teladoc Health Reports Q3 2024 Financial Results - TipRanks
Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Teladoc (NYSE:TDOC) Surprises With Q3 Sales, Stock Jumps 10.3% - Yahoo Finance
Teladoc Health Q3 Earnings: Revenue Beat, EPS Beat, Shares Jump 10% - Benzinga
Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):